Recombinant Human LITAF Protein ，GST

LITAF (lipopolysaccharide-induced TNF-alpha factor) is a pivotal protein involved in the regulation of inflammatory responses and the immune system. Research into LITAF's structure and function has gained momentum due to its critical role in various pathological conditions, including autoimmune diseases, chronic inflammation, and certain cancers. As a transcription factor, LITAF is known to enhance the expression of pro-inflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-α), upon stimulation by lipopolysaccharides (LPS) and other inflammatory signals. The understanding of LITAF's mechanisms and interactions at the molecular level has broad implications for developing targeted therapies, especially in conditions characterized by excessive inflammation. Recent studies have focused on the recombinant expression of LITAF to facilitate functional analyses and structural characterization using techniques such as X-ray crystallography and NMR spectroscopy. The generated recombinant proteins can be utilized in a variety of assays, including binding studies and functional assays, to elucidate the biochemical pathways that LITAF influences. Moreover, understanding how LITAF is modulated in response to various stimuli offers insights into its potential as a therapeutic target. Thus, ongoing research into LITAF recombinant protein not only enhances our grasp of inflammatory processes but also opens avenues for novel interventions in immune-mediated diseases.